ARCHIVES

Interview: A Conversation with Robert Carlson

This article is from The Cancer Letter archive.

Vol. 38 No. 37 | October 5, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Pepper Committee, Impressed By Progress Reports, Promises Help With NCI Funding

June 29, 1979

NSABP Executive Committee Drops Suit Against Pitt

February 10, 1995

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983

NCI Program Develops Bioinformatics Tool To Design Cancer Drugs

September 13, 2002

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986